Evidence map›Paper›PMID 15845493›Full record

ArticleInfection and immunity2005

The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice.

Jason M Gee, Michelle Wright Valderas, Michael E Kovach, Vanessa K Grippe, Gregory T Robertson, Wai-Leung Ng, John M Richardson, Malcolm E Winkler, R Martin Roop

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. A Putative Multicopper Oxidase Encoded byInternational journal of molecular sciences · 2026
    Article
  3. Deletion of the c-di-GMP Phosphodiesterase BpdB AttenuatesInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Proteomic analysis of exosomes fromFrontiers in immunology · 2025
    Article
  8. Article
  9. Infection and immunity · 2022
    Article
  10. Lysine Acylation Modification Landscape ofFrontiers in cell and developmental biology · 2022
    Article
  11. An ArsR Transcriptional Regulator FacilitatesInternational journal of molecular sciences · 2021
    Article
  12. Article
  13. Uncovering the Hidden Credentials ofMicrobiology and molecular biology reviews : MMBR · 2021
    Review
  14. Idiosyncratic Biogenesis of Intracellular Pathogens-Containing Vacuoles.Frontiers in cellular and infection microbiology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Brucella - Virulence Factors, Pathogenesis and Treatment.Polish journal of microbiology · 2018
    Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jason M GeeDepartment of Microbiology and Immunology, East Carolina University School of Medicine, 600 Moye Boulevard, Greenville, NC 27834, USA. roopr@mail.ecu.edu
Michelle Wright Valderas
Michael E Kovach
Vanessa K Grippe
Gregory T Robertson
Wai-Leung Ng
John M Richardson
Malcolm E Winkler
R Martin Roop
Eli Lilly (United States) · USLouisiana State University Health Sciences Center Shreveport · USEast Carolina University · US

Funding

BRUCELLA STATIONARY PHASE GENE EXPRESSION AND VIRULENCER01AI048499 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ROOP, ROY M · 2000 to 2010
$2.8M
Brucella Stationary Phase Gene Expression and VirulenceR21AI048499 · NIAID · EAST CAROLINA UNIVERSITY · PI ROOP, ROY M · 2004 to 2004
$377k
NIAID NIH HHS AI 48499NIAID NIH HHS R01 AI048499NIAID NIH HHS R21 AI048499
6 · The paper itself

Abstract

Two-dimensional gel electrophoretic analysis of cell lysates from Brucella abortus 2308 and the isogenic hfq mutant Hfq3 revealed that the RNA binding protein Hfq (also known as host factor I or HF-I) is required for the optimal stationary phase production of the periplasmic Cu,Zn superoxide dismutase SodC. An isogenic sodC mutant, designated MEK2, was constructed from B. abortus 2308 by gene replacement, and the sodC mutant exhibited much greater susceptibility to killing by O(2)(-) generated by pyrogallol and the xanthine oxidase reaction than the parental 2308 strain supporting a role for SodC in protecting this bacterium from O(2)(-) of exogenous origin. The B. abortus sodC mutant was also found to be much more sensitive to killing by cultured resident peritoneal macrophages from C57BL6J mice than 2308, and the attenuation displayed by MEK2 in cultured murine macrophages was enhanced when these phagocytes were treated with gamma interferon (IFN-gamma). The attenuation displayed by the B. abortus sodC mutant in both resting and IFN-gamma-activated macrophages was alleviated, however, when these host cells were treated with the NADPH oxidase inhibitor apocynin. Consistent with its increased susceptibility to killing by cultured murine macrophages, the B. abortus sodC mutant also displayed significant attenuation in experimentally infected C57BL6J mice compared to the parental strain. These experimental findings indicate that SodC protects B. abortus 2308 from the respiratory burst of host macrophages. They also suggest that reduced SodC levels may contribute to the attenuation displayed by the B. abortus hfq mutant Hfq3 in the mouse model.

Indexed as

Gene Expression Regulation, BacterialRespiratory BurstAnimalsBrucella abortusBrucellosisCells, CulturedFemaleHost Factor 1 ProteinHumansMacrophages, PeritonealMiceMice, Inbred C57BLMutationSuperoxide DismutaseVirulenceHost Factor 1 ProteinSuperoxide Dismutase

Identifiers

PMID15845493
PMCPMC1087332
OpenAlexW2100472522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.